1. Wide skin underming via Wise pattern skin design exposing the entire breast on the breast 'capsule' itself. 2. Circumferential resection of the large and ptotic breast in a dome shaped fashion. 3. Creation of a superior / upper pole glandular ridge. 4. Internal mastopexy by securing the cut superior edge of the newly shaped breast mound to the upper pole glandular ridge with absorbably sutures. 5. Tension free closure of the mammoplasty skin flaps. 
RESULTS:

INTRODUCTION:
Generic preference-based health-related quality-of-life measures such as the EuroQol-5D (EQ-5D) are increasingly used as an outcome measure. They are most useful in economic evaluations, as they can be used to obtain the quality adjusted life years (QALY) of interventions.
Evaluations that use QALY are currently the preferred method for evaluating cost-effectiveness as they allow for comparison across interventions and conditions and are capable of incorporating a societal perspective. The EQ-5D is the gold standard for obtaining such QALYs, yet no EQ-5D reference values are available for the different breast reconstruction (BR) techniques, preventing state-of-the-art cost-effectiveness evaluations of BR. Therefore, we aimed to evaluate the EQ-5D-5L in patients who had undergone postmastectomy BR for breast cancer.
METHODS:
This multi-center cross-sectional survey study included women who had been randomly selected from a 10-year cohort and who had previously undergone a mastectomy for breast cancer either followed by an autologous-BR, an implant-BR or who had not undergone BR. These women were asked to complete the reconstruction module of the Breast-Q, the EORTC-C30 and EORTC-BR23 quality of life questionnaires and the EQ-5D. Propensity score matching was used to compensate for selection bias originating from pretreatment differences between the patient groups.
RESULTS:
After matching of the patient groups the EQ-5D QoL-index-score of either autologous-BR and implant-BR did not differ significantly from one another. However, both showed significantly better QoL-index-scores than patients who had not received a postmastectomy BR. Autologous-BR patients who had experienced complications during treatment reported significantly more pain/discomfort than implant-BR who had experienced complications; an effect that remained over time. Over three-quarters of autologous-BR patients compared to half of implant-BR patients reported pain symptoms; an effect that was not detected by the Breast-Q questionnaire.
CONCLUSION:
In a propensity score-matched comparison of societal preference-based QoL using the EQ-5D we found that overall autologous-BR and implant-BR did not differ significantly from one another but both showed better QoL in comparison to mastectomy only patients. Furthermore, autologous BR-patients who experienced complications during treatment persistently reported more pain/discomfort than implant-BR patients that had complications. The BR QoL reference values from this study will allow state-ofthe-art cost-effectiveness studies using QALYs to be conducted. Considerations of sexual wellbeing may impact a woman's decision about breast cancer surgery or reconstruction. We conducted a systematic review to clarify sexual well-being outcomes after breast cancer surgery.
Sexual Well-Being After Breast Cancer
METHODS:
We searched Medline, Embase, Cochrane, Scopus, and Web of Science for English-language studies about lumpectomy, mastectomy, and/or breast reconstruction in adult female breast cancer patients. Exclusion criteria included cosmetic procedures, non-cancer patients, <10 patients, and non-English language. Two authors independently screened titles/abstracts for eligibility. Data on sexual satisfaction, sexual function, and breast erogenous sensibility were extracted for a qualitative analysis of the literature. Meta-analysis was performed for validated questionnaires to quantitatively evaluate different surgical modalities.
RESULTS:
We identified 1193 studies after deduplication; 104 were eligible for data extraction. The most common study design was crosssectional (51, 49%). Only 47 studies (45%) used validated questionnaires. In meta-analysis of 3 studies (431 patients) using the Cancer Rehabilitation Evaluation System sexual subscale, there was no significant difference between lumpectomy and mastectomy-only for patient-reported sexual well-being (p=0.14). In meta-analysis of 2 studies (103 patients) using the Female Sexual Function Index, patients with reconstruction had higher scores for sexual function compared to mastectomy-only patients (p=0.02). Only 58 studies (56%) presented sexual outcomes for 2 or more surgical treatment groups. Of 26 studies directly comparing mastectomy-only with mastectomy+reconstruction, 10 favored reconstruction (higher sexual satisfaction/function), 3 favored mastectomy-only, and 13 found no significant difference. 16 studies compared lumpectomy with mastectomy+reconstruction: 6 favored lumpectomy, 2 favored mastectomy+reconstruction, and 8 found no significant difference. Of 25 studies comparing lumpectomy with mastectomy-only, 11 favored lumpectomy, 1 favored mastectomy, and 13 found no significant difference. 15 studies assessed sexual well-being after risk-reducing mastectomy with or without breast reconstruction; of these, only 3 (20%) compared 2 or more surgical treatments on a sexual outcome.
